Literature DB >> 8414031

Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989.

P B Christensen1, T S Jensen, I Tsiropoulos, T Sørensen, M Kjaer, E Højer-Pedersen, M J Rasmussen, E Lehfeldt, B de Fine Olivarius.   

Abstract

We studied the epidemiology of myasthenia gravis (MG) in western Denmark from 1975 to 1989, basing case identification on records from all hospitals in the survey area. The population surveyed was 2.80 million in 1985. The average annual incidence rate was 5.0 per million population (women, 5.9; men, 4.2). The point-prevalence rate (January 1, 1990) was 78 per million population (women, 102; men, 53). In men, the incidence increased after 40 years. In women, the incidence rates showed a bimodal pattern with a peak of 7.0 in the age group 20 to 29 years and a second peak of 11.7 in the age group 70 to 79 years. The differences in sex- and age-specific incidence rates suggest that younger women are more susceptible to MG than younger men. Old men and postmenopausal women had similar rates. When last examined, 21% of the 220 prevalent cases were in remission and 18% were moderately or severely disabled.

Entities:  

Mesh:

Year:  1993        PMID: 8414031     DOI: 10.1212/wnl.43.9.1779

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Maintenance of immune tolerance to a neo-self acetylcholine receptor antigen with aging: implications for late-onset autoimmunity.

Authors:  Sue Stacy; Earlanda L Williams; Nathan E Standifer; Amanda Pasquali; Keith A Krolick; Anthony J Infante; Ellen Kraig
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

2.  Nationwide population-based epidemiological study of myasthenia gravis in taiwan.

Authors:  Chien-Hsu Lai; Hung-Fu Tseng
Journal:  Neuroepidemiology       Date:  2010-06-03       Impact factor: 3.282

Review 3.  Thymectomy for myasthenia gravis.

Authors:  J D Urschel; R P Grewal
Journal:  Postgrad Med J       Date:  1998-03       Impact factor: 2.401

Review 4.  Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.

Authors:  Yoshihisa Kadota; Hirotoshi Horio; Takeshi Mori; Noriyoshi Sawabata; Taichiro Goto; Shin-ichi Yamashita; Takeshi Nagayasu; Akinori Iwasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-01-22

Review 5.  A systematic review of population based epidemiological studies in Myasthenia Gravis.

Authors:  Aisling S Carr; Chris R Cardwell; Peter O McCarron; John McConville
Journal:  BMC Neurol       Date:  2010-06-18       Impact factor: 2.474

6.  Epidemiology of seropositive myasthenia gravis in Greece.

Authors:  K Poulas; E Tsibri; A Kokla; D Papanastasiou; T Tsouloufis; M Marinou; P Tsantili; T Papapetropoulos; S J Tzartos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

7.  Mortality and survival in myasthenia gravis: a Danish population based study.

Authors:  P B Christensen; T S Jensen; I Tsiropoulos; T Sørensen; M Kjaer; E Højer-Pedersen; M J Rasmussen; E Lehfeldt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

8.  Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy.

Authors:  Karsten Schepelmann; Yaroslav Winter; Annika E Spottke; Detlef Claus; Christoph Grothe; Rolf Schröder; Dieter Heuss; Stefan Vielhaber; Veit Mylius; Reinhard Kiefer; Bertold Schrank; Wolfgang H Oertel; Richard Dodel
Journal:  J Neurol       Date:  2009-07-24       Impact factor: 4.849

9.  A population based epidemiological study on myasthenia gravis in Estonia.

Authors:  M Oöpik; A-E Kaasik; J Jakobsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

10.  Trends in Outcomes and Hospitalization Charges among Mechanically Ventilated Patients with Myasthenia Gravis in the United States.

Authors:  Nizar Souayah; Abu Nasar; M Fareed K Suri; Jawad F Kirmani; Mustapha A Ezzeddine; Adnan I Qureshi
Journal:  Int J Biomed Sci       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.